These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 24107612)

  • 1. Is the low-grade squamous intraepithelial lesion/atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion category associated with cervical intraepithelial neoplasia 2?
    Cetiner H; Kır G; Kaygusuz E; Sağlıcan Y; Kabaca C
    Acta Cytol; 2013; 57(6):581-4. PubMed ID: 24107612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for increasing usage of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) Pap test interpretations.
    Walavalkar V; Tommet D; Fischer AH; Liu Y; Papa DM; Owens CL
    Cancer Cytopathol; 2014 Feb; 122(2):123-7. PubMed ID: 23983192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature.
    Ince U; Aydin O; Peker O
    Gynecol Oncol; 2011 Apr; 121(1):152-6. PubMed ID: 21211831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S; Li Z; Austin RM; Zhao C
    Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of the diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion.
    Alsharif M; Kjeldahl K; Curran C; Miller S; Gulbahce HE; Pambuccian SE
    Cancer; 2009 Apr; 117(2):92-100. PubMed ID: 19365830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade squamous intraepithelial lesion, cannot rule out high-grade lesion: Diagnosis, histological outcomes and human papillomavirus results.
    Segura SE; Ramos-Rivera G; Hakima L; Suhrland M; Khader S
    Cytopathology; 2019 Jan; 30(1):99-104. PubMed ID: 30187975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests.
    Elsheikh TM; Kirkpatrick JL; Wu HH
    Cancer; 2006 Oct; 108(5):277-81. PubMed ID: 16937376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
    Nasser SM; Cibas ES; Crum CP; Faquin WC
    Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" is a distinct cytologic category: histologic outcomes and HPV prevalence.
    Owens CL; Moats DR; Burroughs FH; Gustafson KS
    Am J Clin Pathol; 2007 Sep; 128(3):398-403. PubMed ID: 17709313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of the diagnosis "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion" in pregnant women.
    Onuma K; Saad RS; Kanbour-Shakir A; Kanbour AI; Dabbs DJ
    Cancer; 2006 Oct; 108(5):282-7. PubMed ID: 16991139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should LSIL-H be a distinct cytology category?: A study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women.
    Zhou H; Schwartz MR; Coffey D; Smith D; Mody DR; Ge Y
    Cancer Cytopathol; 2012 Dec; 120(6):373-9. PubMed ID: 22648956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with negative cervical biopsies after papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": comparative longitudinal follow-up.
    Huitron S; Bonvicino A; Fadare O
    Ann Diagn Pathol; 2008 Jun; 12(3):187-90. PubMed ID: 18486894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of "squamous intraepithelial lesion of indeterminate grade" as a distinct cytologic category.
    Wong D; Teschendorf C; Lin GY; Hasteh F
    Am J Clin Pathol; 2012 May; 137(5):753-60. PubMed ID: 22523214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

  • 18. Defining the Longitudinal Risk of CIN 3+ for Piedimonte S; Tsang K; Jembere N; Murphy J; Karapetian T; Gao J; McCurdy B; Sacco J; Kupets R
    J Low Genit Tract Dis; 2024 Jan; 28(1):7-11. PubMed ID: 37906611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Implementing the Dual Papanicolaou Test Interpretation of ASC-H and LSIL Following Bethesda 2014.
    Goyal A; Patel AP; Dilcher TL; Alperstein SA
    Am J Clin Pathol; 2020 Sep; 154(4):553-558. PubMed ID: 32556080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LSIL/ASC-H (LSIL-H) in cervicovaginal smear: histopathological outcomes and clinical significance.
    Kaygusuz EI; Cetiner H; Sahin D
    Turk Patoloji Derg; 2011 Jan; 27(1):46-50. PubMed ID: 21469426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.